BIOMAT Database Logo BIOMAT Database Logo

Is ECT better than clozapine for treatment-resistant schizophrenia? 2023

Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India.

UI MeSH Term Description Entries
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090663 Schizophrenia, Treatment-Resistant A subset of schizophrenia with an inadequate response in target symptoms following treatment with two or more ANTIPSYCHOTICS. Refractory Schizophrenia,Treatment-Resistant Schizophrenia,Schizophrenia, Refractory,Schizophrenia, Treatment Resistant,Treatment Resistant Schizophrenia
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
June 1996, Convulsive therapy,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Clozapine for Treatment-Resistant Schizophrenia.
January 2016, American journal of therapeutics,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Combination of ECT and clozapine in drug-resistant schizophrenia.
October 2005, Indian journal of psychiatry,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
October 2018, Journal of psychiatric research,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Ect in treatment resistant schizophrenia.
April 2003, Indian journal of psychiatry,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Consider ECT for treatment-resistant childhood schizophrenia.
September 2014, The American journal of psychiatry,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features.
January 2024, Journal of clinical psychopharmacology,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
ECT and clozapine in schizophrenia.
December 1998, The journal of ECT,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS).
August 2021, Nordic journal of psychiatry,
Chithra Uppinkudru, and Vanteemar S Sreeraj, and Shyam Sunder Arumugham, and Samir K Praharaj, and Nishant Goyal, and Preeti Sinha, and Jagadisha Thirthalli
Combined ECT and clozapine in treatment-resistant mania.
June 2000, The journal of ECT,
Copied contents to your clipboard!